AMGN vs SYK
By Alex · Tickerpine
Amgen Inc. vs Stryker Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | SYK |
|---|---|---|
| Price | $358.33 | $332.71 |
| Market cap | $193.39B | $127.55B |
| P/E ratio | 24.9 | 38.5 |
| ROE | 101.32% | 15.20% |
| Profit margin | 20.96% | 13.21% |
| Revenue growth | 5.80% | 2.60% |
| Dividend yield | 2.81% | 1.06% |
| Beta | 0.42 | 0.79 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs SYK in plain English
- AMGN is the bigger company — about 1.5× the market cap of SYK.
- AMGN is cheaper on earnings (P/E 24.9 vs 38.5).
- AMGN earns a higher return on equity (101% vs 15%).
- AMGN is growing revenue faster (6% vs 3%).
- AMGN has the higher dividend yield (2.81% vs 1.06%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
SYK return calculator
See what $1,000 in Stryker Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.